Key points are not available for this paper at this time.
Design
Editorial
Discusses recent insights into the mechanisms of doxorubicin-induced heart failure and potential risk reduction strategies.
Doxorubicin and other anthracyclines are used to treat cancer, yet they elevate the risk of heart failure. A recent study provides insight into how doxorubicin causes heart failure and points to research strategies for reducing risk.
No takes yet. Share an insight, caveat, or question.
Douglas B. Sawyer (2013) studied this question.